Amino acid position 37 of HLA-DRβ1 affects susceptibility to Crohn's disease in Asians

Abstract Crohn's disease (CD) and ulcerative colitis (UC) are the major types of chronic inflammatory bowel disease (IBD) characterized by recurring episodes of inflammation of the gastrointestinal tract. Although it is well established that human leukocyte antigen (HLA) is a major risk factor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human molecular genetics 2018-11, Vol.27 (22), p.3901-3910
Hauptverfasser: Han, Buhm, Akiyama, Masato, Kim, Kyung-Kon, Oh, Hyunjung, Choi, Hyunchul, Lee, Cue Hyunkyu, Jung, Seulgi, Lee, Ho-Su, Kim, Emma E, Cook, Seungho, Haritunians, Talin, Yamazaki, Keiko, Park, Sang Hyoung, Ye, Byong Duk, McGovern, Dermot P B, Esaki, Motohiro, Kawaguchi, Takaaki, Khor, Seik-Soon, Taylor, Kent D, Rotter, Jerome I, Suzuki, Yasuo, Matsui, Toshiyuki, Motoya, Satoshi, Bang, So-Young, Kim, Tae-Hwan, Momozawa, Yukihide, Kamatani, Yoichiro, Tokunaga, Katsushi, Kubo, Michiaki, Okada, Yukinori, Yang, Suk-Kyun, Song, Kyuyoung
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Crohn's disease (CD) and ulcerative colitis (UC) are the major types of chronic inflammatory bowel disease (IBD) characterized by recurring episodes of inflammation of the gastrointestinal tract. Although it is well established that human leukocyte antigen (HLA) is a major risk factor for IBD, it is yet to be determined which HLA alleles or amino acids drive the risks of CD and UC in Asians. To define the roles of HLA for IBD in Asians, we fine-mapped HLA in 12 568 individuals from Korea and Japan (3294 patients with CD, 1522 patients with UC and 7752 controls). We identified that the amino acid position 37 of HLA-DRβ1 plays a key role in the susceptibility to CD (presence of serine being protective, P = 3.6 × 10−67, OR = 0.48 [0.45-0.52]). For UC, we confirmed the known association of the haplotype spanning HLA-C*12:02, HLA-B*52:01 and HLA-DRB1*1502 (P = 1.2 × 10−28, OR = 4.01 [3.14-5.12]).
ISSN:0964-6906
1460-2083
DOI:10.1093/hmg/ddy285